P326: Physicians’ recommendations for travel in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P327: Symptom relevance attributed by inflammatory bowel disease patients has a differential impact on their quality of lifeECCO '18 Vienna
2018
P328: Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)ECCO '18 Vienna
2018
P329: Utility of faecal calprotectin to assess Crohn’s disease activity in patients with an ileostomyECCO '18 Vienna
2018
P330: A prospective trial to evaluate the feasibility of a mobile app in patients with inflammatory bowel disease under maintenance therapyECCO '18 Vienna
2018
P331: Development of a novel transabdominal ultrasound disease activity score in patients with ulcerative colitis (UCUS score)ECCO '18 Vienna
2018
P332: A treat-to target strategy guided by pan-enteric valuation in paediatric Crohn’s disease improves outcomes at 2 yearsECCO '18 Vienna
2018
P333: The baseline features of patients with newly diagnosed moderate-to-severe ulcerative colitis in Korea: A population-based cohort study (the MOSAIK cohort)ECCO '18 Vienna
2018
P334: Does the circadian clock have a role in the pathogenesis of inflammatory bowel disease (IBD)?ECCO '18 Vienna
2018
P336: Is endoscopy necessary to measure disease activity in ulcerative colitis: A systematic narrative reviewECCO '18 Vienna
2018
P337: Low seroprevalence of celiac disease in a large screening study in unselected Swiss IBD cohort patientsECCO '18 Vienna
2018
P338: Outcome of hospitalised patients with inflammatory bowel disease complicated by Clostridium difficile infection: Results from a tertiary referral centreECCO '18 Vienna
2018
P339: Crohn’s disease and self-monitoring through a mobile App: The Medicrohn studyECCO '18 Vienna
2018
P341: Faecal biomarkers compared with MRI using the MaRIA and Clermont scores for monitoring inflammatory activity in patients with Crohn’s diseaseECCO '18 Vienna
2018